This might be related to high-grade gliomas with high expression of O6-methylguanine-DNA-methyltransferase promoter methylation, 1p19q co-deletion, isocitrate dehydrogenase gene mutations (24). The gene discussed is MGMT; the disease is central nervous system cancer.